Axon shares surged after Trump disclosed a $1M-$5M stake, though analysts warn against blindly following celebrity stock picks.
Axon (AXON) shares jumped 10% Monday after federal filings revealed President Trump purchased between $1 million and $5 million of its stock in February. The rally extended another 6.5% Tuesday, though analysts caution investors against treating celebrity trades as conviction signals.
The disclosure coincided with Immigration and Customs Enforcement (ICE) seeking a $220 million Taser contract with Axon, though no evidence links Trump to the procurement process. Shares had previously traded with less volatility, reflecting broader market conditions.
Portfolio managers emphasize the risks of coattailing high-profile investors, noting entry points may align but exit strategies remain unpredictable. Research firm BCA Research suggested identifying stocks before prominent figures do yields greater returns.